| Price | 5.75p on 03-06-2026 at 18:05:09 |
|---|---|
| Change | -0.10p -1.71% |
| Buy | 5.80p |
| Sell | 5.70p |
| Last Trade: | Unknown 50,000.00 at 5.75p |
| Day's Volume: | 1,833,158 |
| Last Close: | 5.75p |
| Open: | 5.85p |
| ISIN: | GB00BYV81293 |
| Day's Range | 5.75p - 5.85p |
| 52wk Range: | 2.40p - 12.35p |
| Market Capitalisation: | £61.50m |
| VWAP: | 5.742438p |
| Shares in Issue: | 1.07b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Shield Thera (STX) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 50,000 | 5.75p | OTC Trade |
17:07:48 - 03-Jun-26 |
| Buy* | 34,456 | 5.79p | Ordinary |
16:23:53 - 03-Jun-26 |
| Unknown* | 50,000 | 5.75p | Ordinary |
16:22:32 - 03-Jun-26 |
| Sell* | 3,324 | 5.72p | Ordinary |
16:00:49 - 03-Jun-26 |
| Sell* | 14 | 5.72p | Ordinary |
15:27:16 - 03-Jun-26 |
| Sell* | 450 | 5.72p | Ordinary |
15:27:04 - 03-Jun-26 |
| Sell* | 15,500 | 5.72p | Ordinary |
15:26:46 - 03-Jun-26 |
| Buy* | 10,416 | 5.76p | Ordinary |
15:14:36 - 03-Jun-26 |
| Buy* | 50,000 | 5.76p | Ordinary |
14:58:46 - 03-Jun-26 |
| Buy* | 69,357 | 5.76p | Ordinary |
14:35:48 - 03-Jun-26 |
Shield Thera (STX) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 29th May 2026 9:11 am | RNS | Total Voting Rights |
| 5th May 2026 7:00 am | RNS | Grant of Share Options |
| 1st May 2026 7:00 am | RNS | Q1 2026 Trading Update |
| 30th Apr 2026 7:01 am | RNS | Total Voting Rights |
| 27th Apr 2026 7:00 am | RNS | Enrollment in Phase II Clinical Trial for ACCRUFeR |
| 9th Apr 2026 12:30 pm | RNS | Audited results for year ended 31 December 2025 |
| 1st Apr 2026 9:22 am | RNS-R | Publication of Report, Reinforcing FDA Approval |
| 31st Mar 2026 7:03 am | RNS | Total Voting Rights |
| 31st Mar 2026 7:00 am | RNS | EMA approves extension - to include adolescents |
| 3rd Mar 2026 7:00 am | RNS | Chinese NMPA Accepts MAA Submission for ACCRUFeR® |
